• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[微小RNA-433通过靶向Notch1逆转乳腺癌细胞对多西他赛的化疗耐药性]

[MiR-433 reverses chemoresistance to docetaxel by targeting Notch1 in breast cancer cells].

作者信息

Hu Xiaolei, Huang Pingmei, Wang Jie, He Wan, Zhao Pan, Yao Guangyu, Ye Changsheng

机构信息

Breast Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Department of Clinical Nutrition, 458 Hospital of PLA, Guangzhou 510602, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2018 Jul 30;38(7):888-894. doi: 10.3969/j.issn.1673-4254.2018.07.20.

DOI:10.3969/j.issn.1673-4254.2018.07.20
PMID:33168512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6765539/
Abstract

OBJECTIVE

To investigate the role of miR- 433 in chemoresistance to docetaxel in breast cancer cells.

METHODS

A docetaxel-resistant MCF-7 breast cancer cell line (MCF-7/DOX) was established by exposure of parental MCF-7 cells to progressively increased docetaxel concentrations. The functional role of miR-433 was investigated by assessing the changes in viability and apoptosis of the cells transfected with a miR-433 inhibitor or a miR-433 mimics. The downstream targets of miR- 433 were determined by bioinformatics analysis, cell transfection and luciferase reporter assay.

RESULTS

Quantitative real-time PCR analysis showed that miR- 433 was down-regulated in MCF-7/DOX cells. Transfection of the cells with the miR-433 inhibitor obviously enhanced chemoresistance to docetaxel and attenuated cell apoptosis in MCF-7 cells; miR-433 overexpression significantly increased the sensitivity to docetaxel and promoted apoptosis in MCF- 7/DOX cells. Luciferase reporter assay showed that the down-regulation miR-433 expression was associated with significantly increased expressions of Notch1 at both mRNA and protein levels in MCF-7 cells. Compared with the control cells, McF-7/DOX cells transfected with miR-433 mimics exhibited significantly decreased mRNA and protein expressions of Notch1.

CONCLUSIONS

miR-433 may reverse chemoresistance to docetaxel by targeting Notch1 in breast cancer cells.

摘要

目的

探讨miR-433在乳腺癌细胞对多西他赛耐药中的作用。

方法

通过将亲本MCF-7细胞暴露于逐渐增加的多西他赛浓度来建立多西他赛耐药的MCF-7乳腺癌细胞系(MCF-7/DOX)。通过评估用miR-433抑制剂或miR-433模拟物转染的细胞的活力和凋亡变化来研究miR-433的功能作用。通过生物信息学分析、细胞转染和荧光素酶报告基因测定来确定miR-433的下游靶点。

结果

定量实时PCR分析表明,MCF-7/DOX细胞中miR-433表达下调。用miR-433抑制剂转染细胞明显增强了MCF-7细胞对多西他赛的耐药性并减弱了细胞凋亡;miR-433过表达显著增加了MCF-7/DOX细胞对多西他赛的敏感性并促进了细胞凋亡。荧光素酶报告基因测定表明,MCF-7细胞中miR-433表达下调与Notch1在mRNA和蛋白质水平的表达显著增加有关。与对照细胞相比,用miR-433模拟物转染的McF-7/DOX细胞Notch1的mRNA和蛋白质表达显著降低。

结论

miR-433可能通过靶向Notch1逆转乳腺癌细胞对多西他赛的耐药性。

相似文献

1
[MiR-433 reverses chemoresistance to docetaxel by targeting Notch1 in breast cancer cells].[微小RNA-433通过靶向Notch1逆转乳腺癌细胞对多西他赛的化疗耐药性]
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Jul 30;38(7):888-894. doi: 10.3969/j.issn.1673-4254.2018.07.20.
2
[miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].[微小RNA-34a可能通过靶向Notch1调节乳腺癌细胞对阿霉素的敏感性]
Zhonghua Zhong Liu Za Zhi. 2014 Dec;36(12):892-6.
3
MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.微小RNA-139-5p通过靶向Notch1抑制乳腺癌细胞的生物学功能,并介导对多西他赛的化疗敏感性。
Biochem Biophys Res Commun. 2015 Oct 2;465(4):702-13. doi: 10.1016/j.bbrc.2015.08.053. Epub 2015 Aug 20.
4
MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.微小RNA-129-3p通过抑制CP110促进乳腺癌细胞对多西他赛的耐药性。
Sci Rep. 2015 Oct 21;5:15424. doi: 10.1038/srep15424.
5
MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.MicroRNA-34a 通过靶向 Notch1 调节乳腺癌细胞对阿霉素的化疗敏感性。
Arch Med Res. 2012 Oct;43(7):514-21. doi: 10.1016/j.arcmed.2012.09.007. Epub 2012 Oct 16.
6
MicroRNA-224 modulates chemosensitivity of breast cancer cells to docetaxel by apoptosis inhibitor 5.MicroRNA-224 通过凋亡抑制因子 5 调节乳腺癌细胞对多西他赛的化疗敏感性。
J BUON. 2021 Mar-Apr;26(2):450-458.
7
miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.miRNA-192-5p 通过靶向脯氨酰肽基顺反异构酶 A 影响乳腺癌细胞对阿霉素的敏感性。
Kaohsiung J Med Sci. 2019 Jan;35(1):17-23. doi: 10.1002/kjm2.12004.
8
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.微小RNA-34a通过直接抑制JAG1/Notch1轴减轻前列腺癌细胞对紫杉醇的耐药性。
Cell Physiol Biochem. 2018;50(1):261-276. doi: 10.1159/000494004. Epub 2018 Oct 3.
9
miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.微小RNA-302a/b/c/d协同抑制乳腺癌耐药蛋白(BCRP)的表达,以提高乳腺癌细胞对药物的敏感性。
Gynecol Oncol. 2016 Jun;141(3):592-601. doi: 10.1016/j.ygyno.2015.11.034. Epub 2015 Nov 28.
10
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 pathway.微小RNA-222通过PTEN/Akt/p27信号通路诱导乳腺癌对阿霉素产生耐药性。
Tumour Biol. 2016 Nov;37(11):15315-15324. doi: 10.1007/s13277-016-5341-2. Epub 2016 Oct 4.

本文引用的文献

1
Adjuvant systemic therapy in older women with breast cancer.老年女性乳腺癌的辅助全身治疗。
Breast Cancer (Dove Med Press). 2016 Jul 25;8:141-7. doi: 10.2147/BCTT.S110765. eCollection 2016.
2
MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.miR-433 通过抑制 Notch1 和 PAX6 的表达抑制视网膜母细胞瘤的恶性转化。
Biomed Pharmacother. 2016 Aug;82:247-55. doi: 10.1016/j.biopha.2016.05.003. Epub 2016 May 13.
3
MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2.微小RNA-770-5p通过靶向切除修复交叉互补基因2抑制人卵巢癌顺铂化疗耐药性。
Oncotarget. 2016 Aug 16;7(33):53254-53268. doi: 10.18632/oncotarget.10736.
4
Management and Outcomes in Metaplastic Breast Cancer.化生性乳腺癌的管理与治疗结果
Clin Breast Cancer. 2016 Dec;16(6):437-443. doi: 10.1016/j.clbc.2016.06.002. Epub 2016 Jun 15.
5
MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.微小RNA-149通过靶向叉头框转录因子FOXM1提高结肠癌细胞对5-氟尿嘧啶的敏感性。
Cell Physiol Biochem. 2016;39(2):617-29. doi: 10.1159/000445653. Epub 2016 Jul 15.
6
Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-κB signaling.靶向Notch1通过抑制核因子-κB信号传导来抑制人乳腺癌细胞的侵袭和血管生成。
Am J Transl Res. 2016 Jun 15;8(6):2681-92. eCollection 2016.
7
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.微小RNA-205靶向血管内皮生长因子A(VEGFA)和成纤维细胞生长因子2(FGF2)并调节乳腺癌对化疗药物的耐药性。
Cell Death Dis. 2016 Jun 30;7(6):e2291. doi: 10.1038/cddis.2016.194.
8
Molecular mechanisms for tumour resistance to chemotherapy.肿瘤对化疗耐药的分子机制。
Clin Exp Pharmacol Physiol. 2016 Aug;43(8):723-37. doi: 10.1111/1440-1681.12581.
9
Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.循环微RNA-451作为乳腺癌新辅助化疗耐药的预测指标
Cancer Biomark. 2016;16(3):395-403. doi: 10.3233/CBM-160578.
10
c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.c-Met和CREB1通过调节Akt/GSK-3β/Snail信号通路参与miR-433介导的膀胱癌上皮-间质转化抑制作用。
Cell Death Dis. 2016 Feb 4;7(2):e2088. doi: 10.1038/cddis.2015.274.